Lobbying Governance
Overall Assessment | Analysis | Score |
---|---|---|
None |
Raffles Medical Group Ltd’s disclosures focus on ESG governance, with its Board and the Audit and Risk Committee providing “corporate governance oversight to ensure that ESG considerations and sustainability material issues continue to be integrated into the Group’s business strategy” and the ARC offering “strategic direction to, and oversight of, our environmental sustainability strategy and climate-related efforts.” However, the company does not disclose any framework, policy, or process for governing its direct or indirect lobbying activities, and it does not name an individual or committee responsible for overseeing lobbying alignment with its climate or sustainability goals. We found no evidence of a lobbying review, alignment procedure, or engagement criteria with trade associations, indicating absence of disclosed lobbying governance.
View Sources
|
E |